Trulieve Cannabis (TCNNF) Stock Analysis & Winston Score
Trulieve Cannabis Corp. is a cannabis company that grows, processes, and sells marijuana products for both medical and recreational use. Its products include flower, vapes, edibles, and concentrates, sold directly to consumers through its own retail dispensaries. Trulieve is one of the largest cannabis retailers in the United States by store count and revenue. The company makes money primarily by selling cannabis products through its dispensaries, which it owns and operates itself — a vertically integrated model that helps protect its margins. Trulieve started in Florida, where it built a dominant market position, and has since expanded into states like Pennsylvania, Georgia, and Arizona. The biggest risk the company faces is that cannabis remains illegal at the federal level in the U.S., which limits its access to banking, raises its taxes significantly, and prevents it from crossing state lines with products — all of which weigh on profitability and growth.
Winston Score: 38/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (13/30)
- Growth: Weak (2/20)
- Cash Flow: Mixed (4/10)
- Stability: Strong (7/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $8.30
Market Cap: $1.6B
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Other OTC

